Ozaras R - Search Results

1

Treating hepatitis B virus/hepatitis C virus coinfected patients with direct-acting hepatitis C virus antivirals only is not safe.

Ozaras R, Sunbul M, Parlak M, Bodur H, Leblebicioglu H. Ozaras R, et al. Hepatology. 2016 Nov;64(5):1825-1827. doi: 10.1002/hep.28592. Epub 2016 May 24. Hepatology. 2016. PMID: 27043022 No abstract available.

2

Therapeutic vaccination in chronic hepatitis B.

Senturk H, Tabak F, Akdogan M, Erdem L, Mert A, Ozaras R, Sander E, Ozbay G, Badur S. Senturk H, et al. Among authors: ozaras r. J Gastroenterol Hepatol. 2002 Jan;17(1):72-6. doi: 10.1046/j.1440-1746.2002.02652.x. J Gastroenterol Hepatol. 2002. PMID: 11895556 Clinical Trial.

3

Hepatitis C virus risk factors in the Turkish community.

Yildirim B, Tahan V, Ozaras R, Aytekin H, Mert A, Tabak F, Senturk H. Yildirim B, et al. Among authors: ozaras r. Dig Dis Sci. 2005 Dec;50(12):2352-5. doi: 10.1007/s10620-005-3061-3. Dig Dis Sci. 2005. PMID: 16416188

4

Permanent visual loss despite appropriate therapy in tuberculous meningitis.

Sunbul M, Leblebicioglu H, Turan D, Esen S, Onder A, Ozaras R, Ozturk R. Sunbul M, et al. Among authors: ozaras r. South Med J. 2007 Feb;100(2):228-9. doi: 10.1097/SMJ.0b013e31802ef8cd. South Med J. 2007. PMID: 17330705 No abstract available.

5

To define virological response in hepatitis B e antigen-negative patients.

Ozaras R, Leblebicioglu H, Eroglu C. Ozaras R, et al. Hepatology. 2008 Apr;47(4):1425; author reply 1425-6. doi: 10.1002/hep.22233. Hepatology. 2008. PMID: 18322938 No abstract available.

6

Autoimmune hepatitis induced by the prolonged hepatitis A virus infection.

Tabak F, Ozdemir F, Tabak O, Erer B, Tahan V, Ozaras R. Tabak F, et al. Among authors: ozaras r. Ann Hepatol. 2008 Apr-Jun;7(2):177-9. Ann Hepatol. 2008. PMID: 18626439 Free article.

7

How to compare antivirals in the treatment of chronic hepatitis B?

Ozaras R, Leblebicioglu H. Ozaras R, et al. Ann Clin Microbiol Antimicrob. 2009 Mar 2;8:6. doi: 10.1186/1476-0711-8-6. Ann Clin Microbiol Antimicrob. 2009. PMID: 19254373 Free PMC article. No abstract available.

8

Acute hepatitis C: prevention and treatment.

Ozaras R, Tahan V. Ozaras R, et al. Expert Rev Anti Infect Ther. 2009 Apr;7(3):351-61. doi: 10.1586/eri.09.8. Expert Rev Anti Infect Ther. 2009. PMID: 19344247 Review.

9

Predictors associated with treatment initiation and switch in a real-world chronic hepatitis B population from five European countries.

Leblebicioglu H, Arama V, Causse X, Marcellin P, Ozaras R, Postawa-Klozinska B, Simon K, Suceveanu AI, Wiese M, Zeuzem S, Klauck I, Morais E, Bjork S, Lescrauwaet B, Kamar D, Zarski JP; AI463-121 European Longitudinal Chronic Hepatitis B Study Group. Leblebicioglu H, et al. Among authors: ozaras r. J Viral Hepat. 2014;21(9):662-70. doi: 10.1111/jvh.12202. Epub 2013 Dec 15. J Viral Hepat. 2014. PMID: 24329883

10

First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment.

Ozaras R, Mete B, Ceylan B, Ozgunes N, Gunduz A, Karaosmanoglu H, Cagatay A, Gokturk K, Erdem L, Kocak F, Senates E, Tabak F. Ozaras R, et al. Eur J Gastroenterol Hepatol. 2014 Jul;26(7):774-80. doi: 10.1097/MEG.0000000000000099. Eur J Gastroenterol Hepatol. 2014. PMID: 24901822 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters